Search research articles
Contact Us
Filters
Showing results (971-980 of 1,023) with videos related to
Page
of 103
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2017
Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer
E E W Cohen, L F Licitra, B Burtness, et al.
Science Translational Medicine
|
December 8, 2017
A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection
Michael C Sneller, J Shawn Justement, Kathleen R Gittens, et al.
Cancer Research
|
March 11, 2010
A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers
S Michael Rothenberg, Gayatry Mohapatra, Miguel N Rivera, et al.
British Journal of Anaesthesia
|
August 11, 2023
An anchor-tether 'hindered' HCN1 inhibitor is antihyperalgesic in a rat spared nerve injury neuropathic pain model
Gareth R Tibbs, Rajendra Uprety, J David Warren, et al.
Nature Communications
|
July 25, 2022
Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC
Robert Saddawi-Konefka, Aoife O'Farrell, Farhoud Faraji, et al.
Journal of Virology
|
August 23, 2019
Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial
Shuying S Li, Peter B Gilbert, Lindsay N Carpp, et al.
JAMA Oncology
|
June 23, 2018
Effect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck: The Active8 Randomized Clinical Trial
Robert L Ferris, Nabil F Saba, Barbara J Gitlitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 22, 2025
INDUCE-3: A randomized Phase II/III study of first-line feladilimab plus pembrolizumab in patients with recurrent/metastatic head and neck squamous cell carcinoma
Danny Rischin, Aaron R Hansen, Ezra E W Cohen, et al.
Nature
|
December 14, 2017
Origin and differentiation of human memory CD8 T cells after vaccination
Rama S Akondy, Mark Fitch, Srilatha Edupuganti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 25, 2014
Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas
Tanguy Y Seiwert, Zhixiang Zuo, Michaela K Keck, et al.
Page
of 103
Search research articles
Search
Showing results (971-980 of 1,023) with videos related to
Sort By:
Page
of 103
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2017
Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer
E E W Cohen, L F Licitra, B Burtness, et al.
Science Translational Medicine
|
December 8, 2017
A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection
Michael C Sneller, J Shawn Justement, Kathleen R Gittens, et al.
Cancer Research
|
March 11, 2010
A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers
S Michael Rothenberg, Gayatry Mohapatra, Miguel N Rivera, et al.
British Journal of Anaesthesia
|
August 11, 2023
An anchor-tether 'hindered' HCN1 inhibitor is antihyperalgesic in a rat spared nerve injury neuropathic pain model
Gareth R Tibbs, Rajendra Uprety, J David Warren, et al.
Nature Communications
|
July 25, 2022
Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC
Robert Saddawi-Konefka, Aoife O'Farrell, Farhoud Faraji, et al.
Journal of Virology
|
August 23, 2019
Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial
Shuying S Li, Peter B Gilbert, Lindsay N Carpp, et al.
JAMA Oncology
|
June 23, 2018
Effect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck: The Active8 Randomized Clinical Trial
Robert L Ferris, Nabil F Saba, Barbara J Gitlitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 22, 2025
INDUCE-3: A randomized Phase II/III study of first-line feladilimab plus pembrolizumab in patients with recurrent/metastatic head and neck squamous cell carcinoma
Danny Rischin, Aaron R Hansen, Ezra E W Cohen, et al.
Nature
|
December 14, 2017
Origin and differentiation of human memory CD8 T cells after vaccination
Rama S Akondy, Mark Fitch, Srilatha Edupuganti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 25, 2014
Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas
Tanguy Y Seiwert, Zhixiang Zuo, Michaela K Keck, et al.
Page
of 103